Androgen Deprivation Therapy Global Market Report 2025

Description

Androgen deprivation therapy is a treatment approach aimed at lowering or inhibiting the activity of male hormones in the body to restrict the growth of hormone-dependent cells. These hormones are vital for many physiological functions, and reducing their levels can have a significant impact on cellular behavior and biological processes.

The primary forms of androgen deprivation therapy include medication, surgery, and other methods. Medication-based ADT uses drugs to decrease or block androgen production. These drugs can be administered through various methods, such as injections or oral intake, and are prescribed to different patient groups, including men aged 40-60, 61-75, and those over 75. This therapy is primarily applied in the treatment of prostate cancer and other conditions, and is utilized by healthcare providers such as hospitals and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The androgen deprivation therapy market research report is one of a series of new reports from The Business Research Company that provides androgen deprivation therapy market statistics, including androgen deprivation therapy industry global market size, regional shares, competitors with a androgen deprivation therapy market share, detailed androgen deprivation therapy market segments, market trends and opportunities, and any further data you may need to thrive in the androgen deprivation therapy industry. This androgen deprivation therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The androgen deprivation therapy market size has grown strongly in recent years. It will grow from $7.81 billion in 2024 to $8.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be linked to the increasing global incidence of prostate cancer, an expanding aging male population, a high rate of cancer recurrence, enhanced survival rates promoting prolonged treatment, and heightened awareness of early prostate cancer screening.

The androgen deprivation therapy market size is expected to see strong growth in the next few years. It will grow to $10.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth expected in the forecast period is driven by greater use of combination therapies in cancer treatment, a rising number of hormone-sensitive cancer cases, increased diagnosis of both localized and advanced prostate cancer, broader application of ADT for hormonal conditions beyond oncology, and a growing patient preference for non-invasive treatments. Key trends during this time include improvements in depot formulations and delivery systems, the development of oral ADT medications, the introduction of long-acting injectable ADT, the emergence of new androgen receptor inhibitors, and technological progress in digital pathology and diagnostic tools.

The rising number of prostate cancer cases is expected to drive the growth of the androgen deprivation therapy market in the coming years. Prostate cancer starts in the prostate gland, which is part of the male reproductive system and produces seminal fluid. The increase in cases is primarily due to longer lifespans, as aging significantly raises the risk of developing this cancer. Androgen deprivation therapy (ADT) is a key treatment option that works by reducing androgen levels, which fuel tumor growth. It is commonly used in advanced or metastatic prostate cancer to slow disease progression. For example, in January 2025, Prostate Cancer UK reported that prostate cancer diagnoses in England rose from 50,751 cases in 2022 to 55,033 cases in 2023, showing a noticeable increase in annual incidence. Therefore, the growing number of prostate cancer cases is boosting the androgen deprivation therapy market.

Leading companies in the androgen deprivation therapy market are focused on developing advanced treatments, including combination therapies, to improve outcomes in advanced prostate cancer. Combination therapy uses multiple treatments, such as hormone therapy alongside chemotherapy, to increase effectiveness and delay disease progression. For instance, in August 2022, Bayer AG received approval from the U.S. Food and Drug Administration for darolutamide combined with docetaxel to treat metastatic hormone-sensitive prostate cancer (mHSPC). This newly approved combination therapy aims to improve survival rates and delay disease advancement in patients whose cancer has spread but still responds to hormone therapy. Darolutamide, an oral drug, uniquely binds tightly to androgen receptors, blocking their activity and helping to inhibit prostate cancer cell growth and spread.

In February 2025, Tempus, a U.S.-based health technology company, partnered with Artera to introduce ArteraAI Prostate Test, an advanced prostate cancer risk assessment tool. This collaboration uses artificial intelligence to improve cancer prognosis accuracy and support better medical decision-making. The ArteraAI digital pathology test, recognized in the NCCN guidelines, helps identify patients with intermediate localized prostate cancer who are more likely to benefit from short-term androgen deprivation therapy. Artera is a U.S.-based digital health company.

Major players in the androgen deprivation therapy market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Astellas Pharma Inc., Ipsen S.A., Dr. Reddy's Laboratories Ltd., Orion Corporation, Arvinas Inc., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Verity Pharmaceuticals Inc., and Lawley Pharmaceuticals Pty Ltd.

North America was the largest region in the androgen deprivation therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in androgen deprivation therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the androgen deprivation therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The androgen deprivation therapy market consists of revenues earned by entities by providing services such as hormonal assessment, monitoring services, telehealth consultations, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The androgen deprivation therapy market also includes sales of hormone monitoring test kits, implantable hormone delivery systems, topical hormone regulation products, and patient monitoring devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Androgen Deprivation Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on androgen deprivation therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for androgen deprivation therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The androgen deprivation therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Medicine; Surgery; Other Types
2) By Route Of Administration: Injectable; Oral
3) By Patient Demographics: Men Aged 40-60; Men Aged 61-75; Men Above 75
4) By Application: Prostate Cancer; Other Applications
5) By End-User: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Medicine: LHRH Agonists; LHRH Antagonists; Anti-Androgens; CYP17 Inhibitors; Steroidal Anti-Androgens; Non-Steroidal Anti-Androgens; Estrogen-Based Therapies; Combination Therapies
2) By Surgery: Bilateral Orchiectomy; Subcapsular Orchiectomy; Simple Orchiectomy
3) By Other Types: Radiopharmaceutical Therapy; Gene Therapy; Immunotherapy; Targeted Therapy; Cryotherapy; High-Intensity Focused Ultrasound (HIFU
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Bristol-Myers Squibb Company; AstraZeneca PLC; Novartis AG; Astellas Pharma Inc.; Ipsen S.A.; Dr. Reddy's Laboratories Ltd.; Orion Corporation; Arvinas Inc.; Ferring Pharmaceuticals SA; Tolmar Pharmaceuticals Inc.; Besins Healthcare S.A.; Veru Inc.; Kintor Pharmaceutical Limited; Foresee Pharmaceuticals Co. Ltd.; Verity Pharmaceuticals Inc.; Lawley Pharmaceuticals Pty Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r36921

1. Executive Summary

2. Androgen Deprivation Therapy Market Characteristics

3. Androgen Deprivation Therapy Market Trends And Strategies

4. Androgen Deprivation Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Androgen Deprivation Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Androgen Deprivation Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Androgen Deprivation Therapy Market Growth Rate Analysis
5.4. Global Androgen Deprivation Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Androgen Deprivation Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Androgen Deprivation Therapy Total Addressable Market (TAM)

6. Androgen Deprivation Therapy Market Segmentation

6.1. Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medicine
Surgery
Other Types
6.2. Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Oral
6.3. Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Men Aged 40-60
Men Aged 61-75
Men Above 75
6.4. Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostate Cancer
Other Applications
6.5. Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
6.6. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
LHRH Agonists
LHRH Antagonists
Anti-Androgens
CYP17 Inhibitors
Steroidal Anti-Androgens
Non-Steroidal Anti-Androgens
Estrogen-Based Therapies
Combination Therapies
6.7. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bilateral Orchiectomy
Subcapsular Orchiectomy
Simple Orchiectomy
6.8. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiopharmaceutical Therapy
Gene Therapy
Immunotherapy
Targeted Therapy
Cryotherapy
High-Intensity Focused Ultrasound (HIFU)

7. Androgen Deprivation Therapy Market Regional And Country Analysis

7.1. Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Androgen Deprivation Therapy Market

8.1. Asia-Pacific Androgen Deprivation Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Androgen Deprivation Therapy Market

9.1. China Androgen Deprivation Therapy Market Overview
9.2. China Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Androgen Deprivation Therapy Market

10.1. India Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Androgen Deprivation Therapy Market

11.1. Japan Androgen Deprivation Therapy Market Overview
11.2. Japan Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Androgen Deprivation Therapy Market

12.1. Australia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Androgen Deprivation Therapy Market

13.1. Indonesia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Androgen Deprivation Therapy Market

14.1. South Korea Androgen Deprivation Therapy Market Overview
14.2. South Korea Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Androgen Deprivation Therapy Market

15.1. Western Europe Androgen Deprivation Therapy Market Overview
15.2. Western Europe Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Androgen Deprivation Therapy Market

16.1. UK Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Androgen Deprivation Therapy Market

17.1. Germany Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Androgen Deprivation Therapy Market

18.1. France Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Androgen Deprivation Therapy Market

19.1. Italy Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Androgen Deprivation Therapy Market

20.1. Spain Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Androgen Deprivation Therapy Market

21.1. Eastern Europe Androgen Deprivation Therapy Market Overview
21.2. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Androgen Deprivation Therapy Market

22.1. Russia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Androgen Deprivation Therapy Market

23.1. North America Androgen Deprivation Therapy Market Overview
23.2. North America Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Androgen Deprivation Therapy Market

24.1. USA Androgen Deprivation Therapy Market Overview
24.2. USA Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Androgen Deprivation Therapy Market

25.1. Canada Androgen Deprivation Therapy Market Overview
25.2. Canada Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Androgen Deprivation Therapy Market

26.1. South America Androgen Deprivation Therapy Market Overview
26.2. South America Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Androgen Deprivation Therapy Market

27.1. Brazil Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Androgen Deprivation Therapy Market

28.1. Middle East Androgen Deprivation Therapy Market Overview
28.2. Middle East Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Androgen Deprivation Therapy Market

29.1. Africa Androgen Deprivation Therapy Market Overview
29.2. Africa Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Androgen Deprivation Therapy Market Competitive Landscape And Company Profiles

30.1. Androgen Deprivation Therapy Market Competitive Landscape
30.2. Androgen Deprivation Therapy Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Androgen Deprivation Therapy Market Other Major And Innovative Companies

31.1. AstraZeneca PLC
31.2. Novartis AG
31.3. Astellas Pharma Inc.
31.4. Ipsen S.A.
31.5. Dr. Reddy's Laboratories Ltd.
31.6. Orion Corporation
31.7. Arvinas Inc.
31.8. Ferring Pharmaceuticals SA
31.9. Tolmar Pharmaceuticals Inc.
31.10. Besins Healthcare S.A.
31.11. Veru Inc.
31.12. Kintor Pharmaceutical Limited
31.13. Foresee Pharmaceuticals Co. Ltd.
31.14. Verity Pharmaceuticals Inc.
31.15. Lawley Pharmaceuticals Pty Ltd.

32. Global Androgen Deprivation Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Androgen Deprivation Therapy Market

34. Recent Developments In The Androgen Deprivation Therapy Market

35. Androgen Deprivation Therapy Market High Potential Countries, Segments and Strategies

35.1 Androgen Deprivation Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Androgen Deprivation Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Androgen Deprivation Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer